Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0783 per EA under NDC 33342005207. Its NADAC has been published 252 times since Oct 27, 2021.
FDA first approved this application on Aug 9, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342005207
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202289FDA Approved
8/9/2012
TE Code
AB
On Market Since
5/3/2012
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 252 times since Oct 27, 2021, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0783 per EA |
|---|---|
| All-time high | $0.2811 (May 11, 2022) |
| All-time low | $0.0771 (Jul 22, 2026) |
| 52-week high | $0.0876 |
| 52-week low | $0.0771 |
| Median price | $0.1245 |
| Average price | $0.1235 |
| Largest weekly change | +33.4% (Apr 20, 2022) |
| Weeks tracked | 252 |
| Tracking since | Oct 27, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.0783 per EA (NDC 33342005207), effective Aug 19, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 54.0%. It has been tracked across 252 weekly CMS publications since Oct 27, 2021.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
Since Oct 27, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0771 (Jul 22, 2026) to a high of $0.2811 (May 11, 2022), with a median of $0.1245 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 33342005207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.